McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
687.52
-5.94 (-0.86%)
At close: May 12, 2025, 4:00 PM
675.50
-12.02 (-1.75%)
After-hours: May 12, 2025, 7:33 PM EDT
McKesson Market Cap
McKesson has a market cap or net worth of $86.02 billion as of May 12, 2025. Its market cap has increased by 22.26% in one year.
Market Cap
86.02B
Enterprise Value
87.74B
1-Year Change
22.26%
Ranking
Category
Stock Price
$687.52
Market Cap Chart
Since December 1, 1998, McKesson's market cap has increased from $7.05B to $86.02B, an increase of 1,120.40%. That is a compound annual growth rate of 9.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 86.76B | 19.93% |
Dec 31, 2024 | 72.34B | 17.43% |
Dec 29, 2023 | 61.61B | 15.82% |
Dec 30, 2022 | 53.19B | 40.15% |
Dec 31, 2021 | 37.95B | 35.91% |
Dec 31, 2020 | 27.93B | 12.04% |
Dec 31, 2019 | 24.92B | 15.48% |
Dec 31, 2018 | 21.58B | -33.61% |
Dec 29, 2017 | 32.51B | 2.39% |
Dec 30, 2016 | 31.75B | -30.03% |
Dec 31, 2015 | 45.38B | -5.71% |
Dec 31, 2014 | 48.13B | 29.83% |
Dec 31, 2013 | 37.08B | 62.00% |
Dec 31, 2012 | 22.89B | 19.63% |
Dec 30, 2011 | 19.13B | 7.42% |
Dec 31, 2010 | 17.81B | 6.34% |
Dec 31, 2009 | 16.75B | 58.13% |
Dec 31, 2008 | 10.59B | -44.13% |
Dec 31, 2007 | 18.96B | 26.34% |
Dec 29, 2006 | 15.01B | -5.46% |
Dec 30, 2005 | 15.87B | 71.66% |
Dec 31, 2004 | 9.25B | -1.34% |
Dec 31, 2003 | 9.37B | 19.10% |
Dec 31, 2002 | 7.87B | -26.43% |
Dec 31, 2001 | 10.70B | 4.95% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 654.16B |
Johnson & Johnson | 369.48B |
UnitedHealth Group | 348.82B |
AbbVie | 331.43B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.59B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |